AUD 0.17
(-2.86%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | -877.24 Thousand AUD | 0.0% |
2023 | - AUD | 0.0% |
2022 | - AUD | 0.0% |
2021 | - AUD | 0.0% |
2020 | - AUD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | - AUD | 0.0% |
2024 Q2 | - AUD | 0.0% |
2024 Q1 | - AUD | -100.0% |
2024 Q4 | -877.24 Thousand AUD | 0.0% |
2024 FY | - AUD | 0.0% |
2023 Q2 | - AUD | 0.0% |
2023 Q1 | - AUD | 0.0% |
2023 Q3 | - AUD | 0.0% |
2023 Q4 | 56.82 Thousand AUD | 0.0% |
2023 FY | - AUD | 0.0% |
2022 Q2 | - AUD | 0.0% |
2022 Q1 | - AUD | 0.0% |
2022 FY | - AUD | 0.0% |
2022 Q4 | - AUD | 0.0% |
2022 Q3 | - AUD | 0.0% |
2021 Q1 | - AUD | 0.0% |
2021 FY | - AUD | 0.0% |
2021 Q4 | - AUD | 0.0% |
2021 Q3 | - AUD | 0.0% |
2020 FY | - AUD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AdAlta Limited | -1.67 Million AUD | 47.768% |
Acrux Limited | 147 Thousand AUD | 696.762% |
Actinogen Medical Limited | 108.82 Thousand AUD | 906.072% |
AnteoTech Limited | 221.85 Thousand AUD | 495.408% |
Argenica Therapeutics Limited | - AUD | Infinity% |
Arovella Therapeutics Limited | - AUD | Infinity% |
Anatara Lifesciences Ltd | -671.09 Thousand AUD | -30.718% |
Alterity Therapeutics Limited | 1.00 AUD | 87724100.0% |
Amplia Therapeutics Limited | - AUD | Infinity% |
Avecho Biotechnology Limited | 97.11 Thousand AUD | 1003.282% |
Bio-Gene Technology Limited | - AUD | Infinity% |
Biome Australia Limited | 1.88 Million AUD | 146.45% |
Biotron Limited | - AUD | Infinity% |
Botanix Pharmaceuticals Limited | 1.2 Million AUD | 172.537% |
BTC Health Limited | - AUD | Infinity% |
Chimeric Therapeutics Limited | - AUD | Infinity% |
CSL Limited | 8.93 Billion AUD | 100.01% |
Clarity Pharmaceuticals Ltd | - AUD | Infinity% |
Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 108.255% |
Cynata Therapeutics Limited | 108.2 Thousand AUD | 910.728% |
Dimerix Limited | - AUD | Infinity% |
EZZ Life Science Holdings Limited | 1.4 Million AUD | 162.607% |
Hexima Limited | - AUD | Infinity% |
Immuron Limited | 1.58 Million AUD | 155.36% |
Immutep Limited | 2.00 AUD | 43862100.0% |
Imugene Limited | - AUD | Infinity% |
Invex Therapeutics Ltd | -94.98 Thousand AUD | -823.576% |
Memphasys Limited | 164.76 Thousand AUD | 632.432% |
Nanollose Limited | - AUD | Infinity% |
Neuren Pharmaceuticals Limited | - AUD | Infinity% |
Noxopharm Limited | -2.35 Million AUD | 62.817% |
NeuroScientific Biopharmaceuticals Limited | - AUD | Infinity% |
Nyrada Inc. | - AUD | Infinity% |
Orthocell Limited | 1.17 Million AUD | 174.555% |
PharmAust Limited | - AUD | Infinity% |
Patrys Limited | - AUD | Infinity% |
Paradigm Biopharmaceuticals Limited | - AUD | Infinity% |
Proteomics International Laboratories Limited | - AUD | Infinity% |
Prescient Therapeutics Limited | - AUD | Infinity% |
PYC Therapeutics Limited | -17.99 Million AUD | 95.125% |
Race Oncology Limited | 16.4 Thousand AUD | 5448.698% |
Radiopharm Theranostics Limited | -987.41 Thousand AUD | 11.158% |
Recce Pharmaceuticals Ltd | - AUD | Infinity% |
Starpharma Holdings Limited | 2.4 Million AUD | 136.43% |
Telix Pharmaceuticals Limited | 17.31 Million AUD | 105.068% |
Tissue Repair Ltd | 214.72 Thousand AUD | 508.547% |
Zelira Therapeutics Limited | 1.25 Million AUD | 170.05% |